Loading chat...
IA SF2154
Bill
Status
1/29/2026
Primary Sponsor
Doug Campbell
Click for details
AI Summary
-
Manufacturers of gene-based vaccines (mRNA, modified mRNA, self-amplifying mRNA, or DNA technology) must conduct integrative transmissibility, DNA contamination, and shedding studies before distributing vaccines within Iowa
-
Distributors of gene-based vaccines that pose an unreasonable risk of harm to public health through transmission or shedding, as determined by the FDA, face a $1,000 fine per occurrence and potential licensing discipline
-
Manufacturers that distribute, sell, or use gene-based vaccines in Iowa are not immune from liability for injury or death caused by design defects in the vaccine
-
The Department of Inspections, Appeals, and Licensing is directed to adopt rules to enforce and administer the new requirements
Legislative Description
A bill for an act relating to the distribution of gene-based vaccines and providing penalties.
Last Action
Subcommittee: Sweeney, Petersen, and Webster. S.J. 199.
2/4/2026